245 related articles for article (PubMed ID: 30779063)
1. MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibit-ing TGF-β1 expression.
Yu SN; Miao YY; Zhang BT; Dai YM; Liu L; Gao ZL; Liu GF
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):972-981. PubMed ID: 30779063
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-487a promotes proliferation of esophageal cancer cells by inhibiting p62 expression.
Ma JB; Hu SL; Zang RK; Su Y; Liang YC; Wang Y
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1502-1512. PubMed ID: 30840272
[TBL] [Abstract][Full Text] [Related]
4. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N
J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-130b-5p accelerates the migration and invasion of osteosarcoma via binding to TIMP2.
Cheng ZH; Luo C; Guo ZL
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9267-9276. PubMed ID: 31773678
[TBL] [Abstract][Full Text] [Related]
6. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2.
Dong JS; Wu B; Zha ZL
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10248-10256. PubMed ID: 31841179
[TBL] [Abstract][Full Text] [Related]
8. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
[TBL] [Abstract][Full Text] [Related]
9. CD151 promotes breast cancer metastasis by activating TGF-β1/Smad signaling pathway.
Zhao SJ; Zhao HD; Li J; Zhang H; Gao DT; Wang Q
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7314-7322. PubMed ID: 30468476
[TBL] [Abstract][Full Text] [Related]
10. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
Yang J; Du YM; Li B
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
[TBL] [Abstract][Full Text] [Related]
11. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
Zeng TD; Zheng B; Zheng W; Chen C
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways.
Tian ZG; Zhuang Y; Jin Z; Zhou F; Zhu LF; Shen PC
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5460-5470. PubMed ID: 30229817
[TBL] [Abstract][Full Text] [Related]
13. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
Luo X; Song Y; Tang L; Sun DH; Ji DG
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-449b-5p Suppresses Proliferation, Migration, and Invasion of Osteosarcoma by Targeting c-Met.
Li Q; Lu C; Wang J; Gao M; Gao W
Med Sci Monit; 2019 Aug; 25():6236-6243. PubMed ID: 31425497
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
Wang T; Li W; Li W; Liu L; Zhang H
J BUON; 2019; 24(2):591-598. PubMed ID: 31128011
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-29c-3p inhibits osteosarcoma cell proliferation through targeting PIK3R3.
Ma HZ; Wang J; Shi J; Zhang W; Zhou DS
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2239-2247. PubMed ID: 32196574
[TBL] [Abstract][Full Text] [Related]
19. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
[TBL] [Abstract][Full Text] [Related]
20. By targeting TRAF6, miR-140-3p inhibits TGF-β1-induced human osteosarcoma epithelial-to-mesenchymal transition, migration, and invasion.
Guo Q; Zhang N; Liu S; Pang Z; Chen Z
Biotechnol Lett; 2020 Nov; 42(11):2123-2133. PubMed ID: 32562135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]